Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2026	Sep. 30, 2025
Cash flows from operating activities
Net income	$ 101,964	$ 7,883
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization	2,021	2,180
Stock-based compensation	8,622	7,526
Amortization of operating ROU assets	4,884	4,957
Deferred income taxes	(89,426)	0
Other	2,283	2,679
Changes in assets and liabilities:
Accounts receivable, net	(11,262)	437
Inventories	20,070	(10,828)
Prepaid expenses and other assets	(758)	2,747
Accounts payable, accrued expenses and other long-term liabilities	1,776	(15,102)
Deferred revenue	0	(288)
Operating lease liabilities	(6,891)	(6,378)
Net cash provided by (used in) operating activities	33,283	(4,187)
Cash flows from investing activities
Purchases of property and equipment	(2,767)	(263)
Net cash used in investing activities	(2,767)	(263)
Cash flows from financing activities
Repurchase of common stock	(25,143)	0
Proceeds from exercise of stock options	7,892	384
Proceeds from 2021 ESPP	108	85
Payments on finance lease liabilities	0	(1)
Net cash (used in) provided by financing activities	(17,143)	468
Net increase (decrease) in cash and cash equivalents	13,373	(3,982)
Cash and cash equivalents
Beginning of the period	89,581	75,435
End of the period	102,954	71,453
Supplemental disclosures of noncash activities
Capital expenditures included in accounts payable and accrued expenses	$ 143	$ 0